Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-05
1996-07-02
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546118, A61K 31435, C07D47104
Patent
active
055322760
ABSTRACT:
Novel imidazopyridine derivatives of the formula ##STR1## wherein R is ##STR2## and R.sup.1, R.sup.2, R.sup.3, R.sup.4, Ar.sup.1, X and Y are as defined in the specification, and their salts, exhibit antagonistic properties toward angiotensin II and can be used for the treatment of hypertension, aldosteronism, cardiac insufficiency and increased intraocular pressure, and of disorders of the central nervous system.
REFERENCES:
patent: 5036049 (1991-07-01), Watkins
patent: 5242928 (1993-09-01), Mederski et al.
patent: 5321137 (1994-06-01), Mederski et al.
patent: 5332750 (1994-07-01), Mederski et al.
patent: 5371226 (1994-12-01), Mederski et al.
patent: 5389642 (1995-02-01), Dorsch et al.
The Merck Manual of Diagnosis and Therapy. Eleventh Edition (1966) p. 472.
Beier Norbert
Dorsch Dieter
Lues Ingeborg
Mederski Werner
Minck Klaus-Otto
Huang Evelyn
Ivy C. Warren
Merck Patent Gesellschaft mit beschrankter Haftung
LandOfFree
Imidazopyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506838